SOPHiA GENETICS SOPH
NASDAQ SOPH
$8.09 -0.21 (-2.53%)
At close: Sep 4, 2026 · 4:00 PM EDT

SOPHiA GENETICS (SOPH) Net Equity Issued and Repurchased (2020 - 2026)

SOPHiA GENETICS's (SOPH) quarterly Net Equity Issued and Repurchased came in at $39.6 million in Q2 2026, up 172.85% quarter-over-quarter from $14.5 million in Q1 2026.

Analysis

SOPHiA GENETICS (SOPH) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends

SOPHiA GENETICS has disclosed Net Equity Issued and Repurchased across 2 years of filings, most recently posting $39.6 million for Q2 2026.

  • In Q2 2026, Net Equity Issued and Repurchased changed N/A year-over-year to $39.6 million; the TTM figure through Jun 2026 stood at $97.0 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, changed N/A from the prior year.
  • Net Equity Issued and Repurchased came in at $39.6 million for Q2 2026 at SOPHiA GENETICS, up from $14.5 million in the prior quarter.
  • In the past five years, Net Equity Issued and Repurchased ranged from a high of $39.6 million in Q2 2026 to a low of $14.5 million in Q1 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Equity Issued and Repurchased (Qtr)
1 Veeva Systems 44.53 Bn 37.29 Bn 695.95 Mn -
2 Waystar Holding 4.81 Bn 4.62 Bn 221.99 Mn -
3 Doximity 4.74 Bn 4.05 Bn 132.93 Mn -
4 CCC Intelligent Solutions Holdings 4.41 Bn 4.30 Bn 210.64 Mn -
5 EverCommerce 1.40 Bn 1.27 Bn 119.50 Mn -
6 Schrodinger 1.32 Bn 904.47 Mn 32.43 Mn -
7 Certara 1.21 Bn 1.03 Bn 58.15 Mn -
8 GoodRx Holdings 1.18 Bn 887.53 Mn 179.41 Mn -
9 Healthstream 853.81 Mn 787.08 Mn 54.72 Mn -
10 SOPHiA GENETICS 554.05 Mn 446.39 Mn 15.06 Mn 39.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 39.55 Mn
Mar 31, 2026 14.50 Mn
Sep 30, 2020 42.98 Mn